Thus, over-expression of GSDMB2, but not GSDMB1, increases breast cancer tumor growth and metastasis in xenografted mice [48] and GEMMs co-expressing GSDMB2 and HER2 oncogene show enhanced breast cancer incidence [41]. This evidence concerns the gene ERBB2 and breast carcinoma.